Patheon to make biologic drug for California firm; Plant in Fiji planned;

> Douglas Pharmaceuticals in Fiji has opened a new warehouse and intends to expand manufacturing. Report

> Valeant Pharmaceuticals ($VRX) is recalling 93,237 bottles of hypertension treater nifedipine extended-release tablets it manufactured for Teva ($TEVA) that dissolve too quickly. Notice

> The National Institutes of Health, which earlier this month closed a compounding facility after discovering fungal contamination, said Monday it has hired an expert on cGMP practices to help it resolve the facility's issues. Release

> Patheon has struck a deal to develop and manufacture a biologic drug for La Jolla, CA-based Inhibrx. Report

And Finally... Nordea Investment Management, the $240 billion asset manager, has written a letter to the 25 largest drugmakers raising concerns that the Indian companies to which they outsource work are polluting the water of local communities with wastewater from manufacturing. Report